HealthCare Journey for Multiple Sclerosis
  • Home
  • About Us
  • Virtual MS Center
    • Q & A for Virtual MS Center
    • Read About Our Virtual MS Center Staff
  • News & Resources
  • Health & Wellness
  • Blogs
    • Physician Blog >
      • Healthcare Provider Blog
    • Physical Therapy Blog
    • Patient Blog
    • Caregiver Blog
    • Research Blogs >
      • "Ask Dr. Debbie" Research Blog
      • Multiple Perspectives In Multiple Sclerosis Research Blog
  • About MS
    • What is MS?
    • Diagnosis
    • Treatment
    • MS Tips
  • Symptoms
    • Balance and Walking Issues
    • Breathing/Respiratory
    • Bowel Dysfunction
    • Cognitive Dysfunction
    • Crying/Laughing Uncontrollably (PBA)
    • Depression and Anxiety
    • Dizziness/Vertigo
    • Dysphagia
    • Fatigue
    • Foot Drop
    • Hearing or Smell or Taste Changes
    • Heat Sensitivity
    • Leg Weakness
    • Loss of Hand Dexterity and Coordination
    • Memory and Mutliple Sclerosis
    • Migraines
    • Numbness/Tingling/Altered Sensation
    • Nystagmus and Oscillopsia
    • Pain
    • Sexual Dysfunction
    • Sleep Issues
    • Spasticity/Spasms/Cramps
    • Speech/Swallowing
    • Urination/Bowel Problems
    • Vision
  • MS Clinics
  • MS Topics
    • Pregnancy and Infertility
    • Caregivers and Family Members
    • Employment and MS
    • Medical Costs and Insurance
    • Pediatric Multiple Sclerosis
  • Register With Us
  • Terms of Use/Privacy/HIPAA
  • MS HealthCare Journey

Welcome to the Virtual MS Center!

Ask any question you want about Multiple Sclerosis and one of our experts will answer it as soon as possible.
CLICK HERE TO ASK YOUR QUESTION!

​COVID-19 AND MULTIPLE SCLEROSIS: Part II - What we think we know

3/25/2020

0 Comments

 
Part II: What we think we know
 
As is often the case, what we think we know in medicine exceeds our grasp of the actual facts. This does not mean we cannot make logical assumptions, better known as educated guesses, based on our prior medical experience with other viral infections. These experiences must guide our advice and recommendations to patients and families until we have a better understanding of COVID-19.
 
First, we do not know how people with multiple sclerosis respond to a COVID-19 infection. When I talk to colleagues in Italy, which is slightly ahead of us in terms of the pandemic, they know their MS patients are getting sick, but they’ve had no time to determine if certain MS patients are more or less susceptible to severe disease. Even my colleagues in the USA are starting to tweet about their anecdotal experience with COVID-19 infections in isolated MS patients. 

These anecdotes are reassuring, but not terribly informative. Since 80-90 % of people with a COVID-19 infection experience relatively mild disease, it is not surprising to hear that individual MS patients on various disease modifying therapies (DMTs) recover well from their COVID-19 infection.

​For the time being we need to pay attention to what we know for sure and not jump to unnecessary conclusions. Here is what we think we know.
 
As pointed out by recent publications from China and in my last blog, there are several risk factors for COVID-19 related pneumonia (severe disease) that apply to everyone, including MS patients.  These known risks include age over 50 (particularly age over 65), male sex, hypertension (treated or untreated), diabetes and cardiovascular disease.  What seems to be unique about COVID-19 infection is the unusual link between the severity of infection (pneumonia) and high blood pressure.

We do not usually see a link between infectious diseases and high blood pressure. Experts on corona viruses tell us that COVID-19 uses a receptor on the surface of cells that line the respiratory system to infect your upper and lower respiratory tract. This receptor, called the angiotensin II receptor, is more numerous (up-regulated in scientific jargon) in people with high blood pressure, apparently making those individuals with high blood pressure wonderful targets for this virus. 

You can think of the angiotensin II receptor as a lock and the COVID-19 virus happens to possess a very good key to that lock, opening the door into your respiratory system.  This seems to be the way that the COVID-19 virus infects all people, not just people with high blood pressure, since we all express the angiotensin II receptor in our respiratory system. However, other factors must be responsible for the increased risk of more severe infections with COVID-19 in people with high blood pressure. 

One possibility is that certain medications taken by people with high blood pressure increase the risk of severe COVID-19 infections by further increasing the number of angiotensin II receptors in the lung or changing other characteristics of the angiotensin II receptor. Stay tuned for more information on this topic that may even be relevant to prevention or treatment. Suffice it to say that most people with high blood pressure with or without treatment will experience mild disease.
 
 
We also know from years of experience and research studies in people with MS and other neurological diseases that there are other factors known to increase the risk of severe respiratory tract infections. These risks include physical disability in any age group defined as anyone spending time in a wheelchair, a prior history of frequent upper respiratory tract infections, pulmonary disease (e.g. asthma, COPD), smoking and immunosuppression. There is no reason to believe that these same characteristics would not also increase the risk of severe COVID-19 infection.  
 
So how do we put all this information together to provide advice to our patients with MS based on, what we think we now?
 
  1. Follow the advice of the CDC and your state health officials. We cannot emphasize enough the importance of social distancing, washing and sheltering at home as much as possible.
  2. We have no reason to believe that relapsing remitting MS patients without physical disability are at any greater risk of severe COVID-19 infections than their healthy peers as long as they do not have any of the risk factors discussed previously (i.e. age > 50, male sex, high blood pressure, diabetes or cardiovascular disease, pulmonary disease, smoking, frequent respiratory infections or immunosuppression)
  3. It is prudent to avoid or postpone immunosuppression with lymphocyte depleting agents, particularly if you are over age 50, a male or have a diagnosis past or present of hypertension, diabetes or heart disease.  Lymphocyte depleting agents include rituximab, ocrelizumab (Ocrevus), Mavenclad (Cladribine), lemtrada (Alemtuzumab) and chemotherapies used to treat MS (cyclophosphamide is an example). There will definitely be some people with MS, whose disease is so active that it is too risky to postpone treatment, but most people will be able to delay treatment with lymphocyte depleting agents until the risk of COVID 19 infections pass.
  4. We do not know if Natalizumab (Tysabri) will increase the frequency or severity of COVID-19 infections. Some studies, notably studies of Tysabri in Crohn’s disease, reported a slightly increased risk of respiratory tract infections, but this risk was not the observed in the MS studies. Tysabri alters normal immune cell trafficking and interactions with the extracellular matrix, particularly in the central nervous system and GI tract, but this does not suppress immune cell function, notably. Some MS specialists may increase the interval between infusions to every 6 to 8 weeks during the pandemic to allay this potential concern. It is important not to stop Tysabri altogether, because of the risk of a rebound relapse.
  5. We have no reason to believe that Beta Interferon treatments (i.e. avonex, betaseron, rebif, extavia and plegridy) will increase the risk or severity of COVID-19 infections. In fact, interferons are being studied as a potential anti-viral treatment for COVID-19 infection.
  6. We have no reason to believe that Copaxone and glatiramer acetate will increase the risk or severity of COVID-19 infection
  7. We do not know if Aubagio, tecfidera, gilenya or mayzent will increase the risk or severity of COVID-19 infections. It is possible that people with MS who experience a significant lowering of their lymphocyte counts on any of these DMTs could experience an increased risk of severe COVID-19 infections. Some MS specialists may alter the dose or dose frequency of these medications, if you are considered at increased risk for severe COVID-19 infection. Talk to your MS specialist to see if you fall into this category of people with MS. But remember that people on Gilenya and Mayzent may also experience a rebound relapse if they suddenly stop treatment.
 
What will happen if you do experience a COVID-19 infection?

Perhaps nothing. Some people just experience mild cold symptoms and some experienced only an alteration of taste and/or smell. Most people feel like they have the flu with fever, body aches, fatigue, congestion and cough. People with MS can expect their MS symptoms to worsen with a COVID-19 infection because of fever and/or a general activation of your immune system. If you do get ill, make sure you stay well hydrated and keep your temperature down with Tylenol (acetaminophen). If your MS worsens significantly your MS specialist may even consider treating you with steroids depending on the severity of the COVID-19 infection. But the best thing to do is not to get infected at all
 
Good luck and stay well

Revere P (Rip) Kinkel, MDProfessor of Clinical Neurosciences
Director of the Multiple Sclerosis Program
Clinical Neurosciences Director
University of California San Diego
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    RSS Feed

    PLEASE NOTE: This information/opinions on this site should be used as an information source only.  This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment.  Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.
    Read About Our Virtual MS Center Authors

    Archives

    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    July 2013
    June 2013

    Categories

    All
    Accessible Housing And Environmental Modifications
    Anxiety
    Balance
    Bowel Problems
    Caregivers
    Cognitive Function
    Compliance
    David Rintell Ed. D.
    Deborah Backus Blogs
    Depression
    Diagnosis
    Diet
    Dizziness
    Dosing
    Dr. Greenberg's Q&A
    Dr. Kinkel's Q&A
    Dr. Miravalle's Q&A
    Dr. Nielsen's Q&A
    Dr. Osborne's Q&A
    Exercise
    Experimental Treatments
    Eye Surgery
    Fatigue
    Fatique
    Flu Shot
    Foot Drop
    Herbs
    Immunosuppression
    JCV
    Lasik Surgery
    Lesions
    Lori Kostich's Q&A
    Lyme Disease
    Medications
    Migraines
    Mobility
    MRI
    MS Hug
    Other Diseases
    Pain
    PML
    PPMS
    Pregnancy
    Relapse
    Safety
    Sarah Wargo's Q&A
    Sexual Dysfunction
    Side Effects
    Smoking
    Spasticity
    Stem Cell Transplantation
    Steroids
    Stress
    Supplements
    Surgery
    Symptoms
    Treatment
    Urination
    Viruses
    Vision
    Vitamin D
    Vitamins
    Weakness


© 2020 HealthCare Journey, LLC. All Rights Reserved.
HealthCare Journey™ is a trademark of HealthCare Journey, LLC
Picture
  • Home
  • About Us
  • Virtual MS Center
    • Q & A for Virtual MS Center
    • Read About Our Virtual MS Center Staff
  • News & Resources
  • Health & Wellness
  • Blogs
    • Physician Blog >
      • Healthcare Provider Blog
    • Physical Therapy Blog
    • Patient Blog
    • Caregiver Blog
    • Research Blogs >
      • "Ask Dr. Debbie" Research Blog
      • Multiple Perspectives In Multiple Sclerosis Research Blog
  • About MS
    • What is MS?
    • Diagnosis
    • Treatment
    • MS Tips
  • Symptoms
    • Balance and Walking Issues
    • Breathing/Respiratory
    • Bowel Dysfunction
    • Cognitive Dysfunction
    • Crying/Laughing Uncontrollably (PBA)
    • Depression and Anxiety
    • Dizziness/Vertigo
    • Dysphagia
    • Fatigue
    • Foot Drop
    • Hearing or Smell or Taste Changes
    • Heat Sensitivity
    • Leg Weakness
    • Loss of Hand Dexterity and Coordination
    • Memory and Mutliple Sclerosis
    • Migraines
    • Numbness/Tingling/Altered Sensation
    • Nystagmus and Oscillopsia
    • Pain
    • Sexual Dysfunction
    • Sleep Issues
    • Spasticity/Spasms/Cramps
    • Speech/Swallowing
    • Urination/Bowel Problems
    • Vision
  • MS Clinics
  • MS Topics
    • Pregnancy and Infertility
    • Caregivers and Family Members
    • Employment and MS
    • Medical Costs and Insurance
    • Pediatric Multiple Sclerosis
  • Register With Us
  • Terms of Use/Privacy/HIPAA
  • MS HealthCare Journey